Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
Paul J. Hampel, Hua‐Jay J. Cherng, Timothy G. Call, Wei Ding, Mahsa Khanlari, Ellen D. McPhail, Roberto N. Miranda, Pei Lin, Hussein A. Tawbi, Alessandra Ferrajoli, William G. Wierda, Nitin Jain, Sameer A. Parikh
Abstract
Key Points An incidental histologic diagnosis of DLBCL was identified during temporary interruption of ibrutinib treatment in patients with CLL. In contrast to an aggressive clinical course typical of Richter transformation, these patients responded to reinitiation of ibrutinib alone.
Topics & Concepts
IbrutinibChronic lymphocytic leukemiaMedicineInternal medicineLeukemiaOncologyChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentGastrointestinal Tumor Research and Treatment